Shuttle Pharmaceuticals Holdings (SHPH) Shares Outstanding (2021 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Shares Outstanding (Entity) came in at $40196.0 in Q1 2025, up 377.95% year-on-year from $8410.0 in Q1 2024, and up 250.14% quarter-over-quarter from $11480.0 in Q4 2024.
Shuttle Pharmaceuticals Holdings (SHPH) Shares Outstanding (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Shares Outstanding (Entity) history runs 5 years deep, the most recent figure standing at $40196.0 for Q1 2025.
- On a quarterly basis, Shares Outstanding (Entity) rose 377.95% year-over-year to $40196.0 in Q1 2025; TTM through Mar 2025 was $40196.0, a 377.95% increase from a year earlier, with the FY2024 full-year figure at $11480.0, up 42.87% from the prior year.
- Shares Outstanding (Entity) advanced to $40196.0 in Q1 2025 per SHPH's latest filing, from $11480.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $40196.0 in Q1 2025 and bottomed at $4646.0 in Q3 2021.
- The 5-year median for Shares Outstanding (Entity) is $7741.0 (2023), against an average of $9168.2.
- Across the five-year window, Shares Outstanding (Entity) advanced 8.84% in 2024 and surged 377.95% in 2025, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $4656.0 in 2021, then rose by 11.17% to $5176.0 in 2022, then surged by 55.24% to $8035.0 in 2023, then soared by 42.87% to $11480.0 in 2024, then soared by 250.14% to $40196.0 in 2025.
- Per Business Quant, the three latest SHPH Shares Outstanding (Entity) figures stand at $40196.0 (Q1 2025), $11480.0 (Q4 2024), and $9537.0 (Q3 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - | 503,157.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 503,157.00 |
| Dec 31, 2025 | 163,793.00 |
| Sep 30, 2025 | 223,365.00 |
| Jun 30, 2025 | 112,605.00 |
| Mar 31, 2025 | 40,196.00 |
| Dec 31, 2024 | 11,480.00 |
| Sep 30, 2024 | 9,537.00 |
| Jun 30, 2024 | 8,420.00 |
| Mar 31, 2024 | 8,286.00 |
| Dec 31, 2023 | 7,460.00 |
| Sep 30, 2023 | 7,872.00 |
| Jun 30, 2023 | 7,131.00 |
| Mar 31, 2023 | 6,818.00 |
| Dec 31, 2022 | 5,176.00 |
| Sep 30, 2022 | 5,082.00 |
| Jun 30, 2022 | 4,656.00 |
| Mar 31, 2022 | 4,656.00 |
| Dec 31, 2021 | 4,651.00 |
| Sep 30, 2021 | 4,646.00 |